-transparent.png){kind=logo}
This study of single-dose cefuroxime treatment of pharyngeal gonorrhea included 13 patients from whose throat specimens taken on the day of treatment Neisseria gonorrhoeae was isolated and who returned for follow-up examinations one and two weeks later. The regimen used was cefuroxime (1.5 g im) plus probenecid (1 g orally). The treatment failed in six patients (46%). Failure of treatment was not associated with decreased in vitro susceptibility of the infecting strain to cefuroxime. In pharyngeal gonorrhea the diagnosis by culture and effective control of treatment require repeated sampling for bacteriologic examinations.
Related Publications
C Graudal, and
A C Bollerup, and
K Lange, and
K Seier, and
I Lind
January 1985,
Sexually transmitted diseases,
C Graudal, and
A C Bollerup, and
K Lange, and
K Seier, and
I Lind
September 1976,
MMW, Munchener medizinische Wochenschrift,
C Graudal, and
A C Bollerup, and
K Lange, and
K Seier, and
I Lind
January 1984,
Sexually transmitted diseases,
C Graudal, and
A C Bollerup, and
K Lange, and
K Seier, and
I Lind
January 1980,
Sexually transmitted diseases,
C Graudal, and
A C Bollerup, and
K Lange, and
K Seier, and
I Lind
January 1984,
Sexually transmitted diseases,
C Graudal, and
A C Bollerup, and
K Lange, and
K Seier, and
I Lind
January 1950,
Vestnik venerologii i dermatologii,
C Graudal, and
A C Bollerup, and
K Lange, and
K Seier, and
I Lind
June 1971,
Revista de saude publica,
C Graudal, and
A C Bollerup, and
K Lange, and
K Seier, and
I Lind
August 1986,
Antimicrobial agents and chemotherapy,
C Graudal, and
A C Bollerup, and
K Lange, and
K Seier, and
I Lind
January 1984,
Sexually transmitted diseases,
C Graudal, and
A C Bollerup, and
K Lange, and
K Seier, and
I Lind
November 1969,
JAMA,
